Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study

BACKGROUND: Predialysis hemoglobin (Hb) may overestimate the true erithropoiesis-stimulating agents (ESA) requeriments. We tested whether predialysis Hb is a reliable predictor of the postdialysis level to better control ESA dosage, and evaluated the relation between ESA, Hb and cardiovascular event...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Castillo, Nieves, García-García, Patricia, Rivero, Antonio, Jiménez-Sosa, Alejandro, Macía, Manuel, Getino, María Adela, Méndez, María Luisa, García-Pérez, Javier, Navarro-González, Juan F
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3444391/
https://ncbi.nlm.nih.gov/pubmed/22799577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-13-60
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky